If you’re a Daily McKnight’s reader, it’s a good thing. Otherwise, you might have never known that a federal measure calling for closer monitoring of antipsychotic drug use in nursing...
Feds’ antipsychotics program fails to reduce prescriptions in assisted living
By
Alicia Lasek
Aug 23, 2022
In a federal initiative to reduce unnecessary antipsychotics prescribing, results in assisted living didn’t match the successes seen in nursing homes, a new study reveals.
Taking antibiotic action
By
Jul 05, 2016
Antipsychotics may soon lose their title as the most maligned medications in healthcare if startling headlines, clinical findings and expert opinions are any evidence.
Group re-assessing antipsychotic label warning
By
Kristen Fischer
Mar 22, 2024
Project PAUSE (Psychoactive Appropriate Use for Safety and Effectiveness) will hold a workshop exploring black box warnings on antipsychotic medication instructions, especially for older adults.
Push to decrease antipsychotics use has only just begun
By
James M. Berklan
Mar 14, 2012
If you feel like you’ve been reading a lot about antipsychotics lately, you’re not alone.
This smart pill is hard to swallow
By
Gary Tetz
Nov 30, 2017
Reading the disturbing news in McKnight’s about the ingestible digital antipsychotic pill that tracks patient data has me all befuddled. I wish I could swallow a pill that would tell me how to feel...
White House to providers: New antibiotic regs on the way
By
Tim Mullaney
Sep 23, 2014
Long-term care providers should take pride in their antipsychotic reduction efforts, and certainly should work hard to meet the new goals announced Friday. But it should not escape their notice that just...
Welcome back to the game, Senators
By
James M. Berklan
May 23, 2012
If you were beginning to worry that some of long-term care’s most prominent needlers had forgotten to show up for work for most of the last year, you weren’t alone. Good news: They’re...
Providers call for broader antipsychotic exclusions to help reduce schizophrenia diagnoses
By
Kimberly Marselas
Mar 31, 2023
Providers and quality experts are questioning why the agency hasn’t done more to review its quality measure for antipsychotic drug use.